Xiaoming Yi
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Physiology top 5%
- Telomeres, Telomerase, and Senescence
Papers in
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
-
- Renal cell carcinoma treatment 8
- Kidney Stones and Urolithiasis Treatments 1
- Co-authors
- Woodring Erik Wright (3 shared papers)Jerry W. Shay (3 shared papers)Chaopeng Tang (11 shared papers)Dara L. Aisner (2 shared papers)Valerie M. Tesmer (2 shared papers)Wenquan Zhou (11 shared papers)Haowei He (11 shared papers)Jingping Ge (7 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Molecular and Cellular Biology (2 papers)Journal of Cellular and Molecular Medicine (1 paper)International Journal of Oncology (1 paper)Science Advances (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoming Yi
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 60
- Cancer Research 254
- Physiology 475
- Drug Discovery 1
- Molecular Biology 221
- Pulmonary and Respiratory Medicine 95
Countries citing papers authored by Xiaoming Yi
This map shows the geographic impact of Xiaoming Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Yi more than expected).
Fields of papers citing papers by Xiaoming Yi
This network shows the impact of papers produced by Xiaoming Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Yi. The network helps show where Xiaoming Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoming Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 169 | |
| 2 | 2001 | 168 | |
| 3 | 1999 | 133 | |
| 4 | 1999 | 96 | |
| 5 | 2016 | 83 | |
| 6 | 2005 | 76 | |
| 7 | 2017 | 66 | |
| 8 | 2015 | 52 | |
| 9 | 2022 | 41 | |
| 10 | 2018 | 40 | |
| 11 | 2021 | 32 | |
| 12 | Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. | 2015 | 25 |
| 13 | 2017 | 19 | |
| 14 | 2016 | 17 | |
| 15 | 2017 | 17 | |
| 16 | 2021 | 16 | |
| 17 | 2008 | 14 | |
| 18 | 2021 | 12 | |
| 19 | 2024 | 9 | |
| 20 | Fast track surgery vs. conventional management in the perioperative care of retroperitoneal laparoscopic adrenalectomy. | 2015 | 8 |
About Xiaoming Yi
Xiaoming Yi is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Physiology, Molecular Biology and Oncology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (8 papers), MicroRNA in disease regulation (4 papers), Telomeres, Telomerase, and Senescence (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (1 paper), Enhanced Recovery After Surgery (1 paper) and Kidney Stones and Urolithiasis Treatments (1 paper). The work is most often cited by research in Cancer Research (254 citations), Physiology (475 citations), Drug Discovery (1 citation), Molecular Biology (221 citations) and Pulmonary and Respiratory Medicine (95 citations). Xiaoming Yi has collaborated with scholars based in China and United States. Frequent co-authors include Woodring Erik Wright, Jerry W. Shay, Chaopeng Tang, Dara L. Aisner, Valerie M. Tesmer, Wenquan Zhou, Haowei He, Jingping Ge, Joseph A. Baur and Isabelle Savre‐Train. Their work appears in journals such as Frontiers in Oncology, Molecular and Cellular Biology, Journal of Cellular and Molecular Medicine, International Journal of Oncology and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.